13 reports

SEDATION IS OFTEN ACHIEVED USING A BENZODIAZEPINE, IN COMBINATION WITH AN OPIOID FOR PAIN RELIEF AND A BARBITURATE-LIKE HYPNOTIC AGENT IF DEEPER SEDATION IS REQUIRED.

  • Colorectal Cancer
  • Arthrex, Inc.
  • Boston Scientific Corporation
  • EndoChoice, Inc.
  • FUJIFILM Holdings Corporation

Other analgesic endpoints, including total pain intensity, time to meaningful pain relief and time to analgesia were also significantly improved versus placebo.

  • Biopharmaceutical
  • Colorectal Cancer
  • United States
  • Product Initiative
  • BioPharma company

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Cancer
  • Colorectal Cancer
  • United States
  • Product Initiative
  • Novartis AG

It is also used for pain and auto-immune indications.

  • Colorectal Cancer
  • Monoclonal Antibody
  • World
  • Product Initiative
  • XBiotech Inc.
  • 5. All the trials included are unique trials.

Pain Relief in Terminally Ill Patients Treatment for Chronic Pain in Patients with Advanced Cancer GDCT## NCT##, SC##; CAN-NCIC-SC##; CDR## Oncology Cancer Pain, Leukemias, Lymphoma, Multiple Myeloma (Kahler Disease), Myelodysplastic Syndrome, Mye

  • Chemotherapy
  • Clinical Trial
  • Colorectal Cancer
  • Pharmaceutical
  • World
  • METASTATIC COLORECTAL CANCER - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2016

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Biotech
  • Colorectal Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.

Exelixis, Inc. reported interim data on pain relief and related reduction in narcotic analgesic use with cabozantinib in castration-resistant prostate cancer (CRPC) patients with bone metastases.

  • Colorectal Cancer
  • Therapy
  • United States
  • Product Initiative
  • Exelixis, Inc.
  • COLORECTAL CANCER - PIPELINE BY GILEAD SCIENCES INC, H2 2017
  • COLORECTAL CANCER - PIPELINE BY GENZYME CORP, H2 2017

The secondary outcome measures of the study were tumor response assessed via CT scan using RECIST and effects on pain relief using a patient self-assessment pain scale.

  • Cell Therapy
  • Colorectal Cancer
  • North America
  • United States
  • Product Initiative

THE COMPANY OFFERS OVER-THE-COUNTER (OTC) PRODUCTS FOR PAIN RELIEF, ORAL HEALTH, NUTRITION, SKIN HEALTH AND RESPIRATORY DISEASES.

  • Colorectal Cancer
  • Hospital
  • Monoclonal Antibody
  • United States
  • Product Initiative

THE COMPANY OFFERS OVER-THE-COUNTER (OTC) PRODUCTS FOR PAIN RELIEF, ORAL HEALTH, NUTRITION, SKIN HEALTH AND RESPIRATORY DISEASES.

  • Colorectal Cancer
  • Hospital
  • Monoclonal Antibody
  • Targeted Therapy
  • GlaxoSmithKline plc
  • COLORECTAL CANCER - PIPELINE BY GLENMARK PHARMACEUTICALS LTD, H1 2017
  • COLORECTAL CANCER - PIPELINE BY GLAXOSMITHKLINE PLC, H1 2017

The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases.

  • Cell Therapy
  • Colorectal Cancer
  • North America
  • United States
  • Product Initiative
  • COLORECTAL CANCER - PIPELINE BY GILEAD SCIENCES INC

THE COMPANY OFFERS OVER-THE-COUNTER (OTC) PRODUCTS FOR PAIN RELIEF, ORAL HEALTH, NUTRITION, SKIN HEALTH AND RESPIRATORY DISEASES.

  • Cancer
  • Colorectal Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.

Exelixis, Inc. reported interim data on pain relief and related reduction in narcotic analgesic use with cabozantinib in castration-resistant prostate cancer (CRPC) patients with bone metastases.

  • Biotech
  • Colorectal Cancer
  • United States
  • Company
  • Product Initiative